Evidence map›Paper›PMID 34830342›Full record

ArticleInternational journal of molecular sciences2021

Osteopontin Deficiency Ameliorates Prostatic Fibrosis and Inflammation.

Petra Popovics, Asha Jain, Kegan O Skalitzky, Elise Schroeder, Hannah Ruetten, Mark Cadena, Kristen S Uchtmann, Chad M Vezina, William A Ricke

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Mechanisms of prostatic inflammation-mediated male lower urinary tract symptoms.American journal of clinical and experimental urology · 2025
    Review
  6. Article
  7. Article
  8. CCR2Scientific reports · 2024
    Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Petra PopovicsDepartment of Urology, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI 53705, USA.ORCID 0000-0002-9179-0575
Asha JainDepartment of Urology, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI 53705, USA.
Kegan O SkalitzkyDepartment of Urology, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI 53705, USA.
Elise SchroederDepartment of Urology, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI 53705, USA.
Hannah RuettenDepartment of Urology, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI 53705, USA.
Mark CadenaDepartment of Urology, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI 53705, USA.
Kristen S UchtmannDepartment of Urology, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI 53705, USA.ORCID 0000-0003-1821-7753
Chad M VezinaDepartment of Urology, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI 53705, USA.ORCID 0000-0001-7058-5399
William A RickeDepartment of Urology, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI 53705, USA.
University of Wisconsin–Madison · US

Funding

UW COMPREHENSIVE CANCER CENTER SUPPORTP30CA014520 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI Christian Capitini · 1985 to 2026
$142.6M
Role of Beta-Catenin in Urinary DysfunctionU54DK104310 · NIDDK · UNIVERSITY OF WISCONSIN-MADISON · PI MACOSKA, JILL A., MARKER, PAUL C · 2014 to 2023
$12.8M
Wisconsin Multidisciplinary K12 Urologic Research Career Development ProgramK12DK100022 · NIDDK · UNIVERSITY OF WISCONSIN-MADISON · PI CHAD M. VEZINA · 2013 to 2026
$8.6M
REPRODUCTIVE AND DEVELOPMENTAL TOXICITY OF DIOXINR01ES001332 · NIEHS · UNIVERSITY OF WISCONSIN-MADISON · PI PETERSON, RICHARD EUGENE, VEZINA, CHAD M. · 1985 to 2021
$5.3M
Elucidating hallmarks of aging in the development of lower urinary tract dysfunction (LUTD)R01DK131175 · NIDDK · UNIVERSITY OF WISCONSIN-MADISON · PI RICKE, WILLIAM A · 2021 to 2024
$2.3M
Estrogen pathways in the development of prostatic fibrosis and lower urinary tract dysfunctionR01DK127081 · NIDDK · UNIVERSITY OF WISCONSIN-MADISON · PI RICKE, WILLIAM A · 2021 to 2024
$2.0M
Osteopontin: A Novel Mediator of prostatic inflammation and fibrosisK01DK127150 · NIDDK · UNIVERSITY OF WISCONSIN-MADISON · PI POPOVICS, PETRA · 2021 to 2025
$630k
Prostate inflammation increases collagen and voiding dysfunctionF30DK122686 · NIDDK · UNIVERSITY OF WISCONSIN-MADISON · PI RUETTEN, HANNAH MARGARET · 2019 to 2022
$157k
NCI NIH HHS P30 CA014520NIDDK NIH HHS F30 DK122686NIDDK NIH HHS F30DK122686NIDDK NIH HHS K01 DK127150-01NIDDK NIH HHS K12 DK100022NIDDK NIH HHS K12 DK100022-06NIDDK NIH HHS R01 DK127081NIDDK NIH HHS R01 DK131175NIDDK NIH HHS U54 DK104310NIEHS NIH HHS R01 ES001332
6 · The paper itself

Abstract

Fibrogenic and inflammatory processes in the prostate are linked to the development of lower urinary tract symptoms (LUTS) in men. Our previous studies identified that osteopontin (OPN), a pro-fibrotic cytokine, is abundant in the prostate of men with LUTS, and its secretion is stimulated by inflammatory cytokines potentially to drive fibrosis. This study investigates whether the lack of OPN ameliorates inflammation and fibrosis in the mouse prostate. We instilled uropathogenic

Indexed as

AnimalsChondroitin Sulfate ProteoglycansCollagen Type IIIDisease Models, AnimalEscherichia coli InfectionsExtracellular Matrix ProteinsFibrosisGene Expression RegulationHumansInflammationLumicanMaleMatrix Metalloproteinase 3MiceMice, Inbred C57BLMice, KnockoutChondroitin Sulfate ProteoglycansCOL3A1 protein, mouseCollagen Type IIIDpt protein, mouseExtracellular Matrix ProteinsLumicanLum protein, mouseMatrix Metalloproteinase 3Mmp3 protein, mouseOsteopontinRNA, MessengerSpp1 protein, mousebenign prostatic hyperplasiachronic inflammationextracellular matrixlower urinary tract symptomsprostatic fibrosis

Identifiers

PMID34830342
PMCPMC8617904
OpenAlexW3214036765

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.